Newbridge Financial Services Group’s Caribou Biosciences CRBU Stock Holding History

Newbridge Financial Services Group’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.52K	Hold	2,000	–	–	﹤0.01%	1018
2026 Q1	$3.8K	Hold	2,000	–	–	﹤0.01%	954
2025 Q4	$3.18K	Hold	2,000	–	–	﹤0.01%	972
2025 Q3	$4.66K	Hold	2,000	–	–	﹤0.01%	1033
2025 Q2	$2.52K	Hold	2,000	–	–	﹤0.01%	1118
2025 Q1	$1.83K	Hold	2,000	–	–	﹤0.01%	900
2024 Q4	$3.18K	Buy	+2,000	New	+$4.02K	﹤0.01%	916
2024 Q3	–	Sell	-2,000	Closed	-$3.28K	–	735
2024 Q2	$3.28K	Hold	2,000	–	–	﹤0.01%	902
2024 Q1	$10.3K	Hold	2,000	–	–	﹤0.01%	763
2023 Q4	$11.5K	Hold	2,000	–	–	0.01%	707
2023 Q3	$9.56K	Buy	+2,000	New	+$12.4K	﹤0.01%	829

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Newbridge Financial Services Group's CRBU Position: Q2 2026 in Review

Newbridge Financial Services Group held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 2,000 shares worth $3.52K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Newbridge Financial Services Group first reported a position in CRBU in Q3 2023 and has held it in 11 quarters since. The position peaked at $11.5K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Newbridge Financial Services Group held 2,000 shares of Caribou Biosciences worth $3.52K as of Q2 2026.
Newbridge Financial Services Group left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1018 holding.
Newbridge Financial Services Group first reported a position in Caribou Biosciences in Q3 2023 and has held it in 11 quarters since.
Newbridge Financial Services Group's Caribou Biosciences position peaked at $11.5K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.